Availability and Use of Social Determinants of Health Data in Alliance Gastrointestinal Cancer Clinical Trials

JCO Oncology Practice · Published 2026-07-07 · DOI 10.1200/op-25-01376

Authors (11)

Kever A. Lewis, Brian A. Colgrove, Garth D. Nelson, Qian Shi, Gretchen C. Edwards, Matthew H. G. Katz, George J. Chang, Electra D. Paskett, Jeffrey A. Meyerhardt, Eileen M. O'Reilly, Rebecca A. Snyder

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lewis, K., Colgrove, B., Nelson, G., et al. (2026). Availability and Use of Social Determinants of Health Data in Alliance Gastrointestinal Cancer Clinical Trials. JCO Oncology Practice. https://doi.org/10.1200/op-25-01376

Related articles

• Acupuncture in Cancer Care: Evidence, Safety, and Implementation in Oncology Practice · JCO Oncology Practice · 2026 · Same journal
• Survival Outcomes in Breast Cancer Patients With Use of Vaginal Estrogen Therapy: A SEER Analysis · JCO Oncology Practice · 2026 · Same journal
• Turnaround Time of Comprehensive Genomic Profiling in Lung Cancer and Other Solid Tumors · JCO Oncology Practice · 2026 · Same journal
• Oral Targeted Anticancer Medications: Use and Spending by Evidence and Magnitude of Clinical Benefit, 2016-2021 · JCO Oncology Practice · 2026 · Same journal
• When Systems Fail the Vulnerable: Cancer Care for Patients With Mental Illness · JCO Oncology Practice · 2026 · Same journal
• Implementing Systems-Based Interventions to Improve the Care of Cancer Survivors: Small Steps, Large Challenges · JCO Oncology Practice · 2026 · Same journal
• Patient Engagement With an Electronic Patient-Reported Outcomes Tool Evaluating Hospital Discharge Readiness After Cancer Surgery · JCO Oncology Practice · 2026 · Same journal
• Participation Is Not Reform: Why 340B Discounts Should Follow the Patient · JCO Oncology Practice · 2026 · Same journal
• Dose Optimization and the Implementation of Project Optimus · JCO Oncology Practice · 2026 · Same journal
• Adoption of Bevacizumab Biosimilars in Medicare Part B: Socioeconomic and Geographic Variation, 2019–2023 · JCO Oncology Practice · 2026 · Same journal